IPC Classification

All sections
A - Human necessities
A61K - Preparations for medical, dental, or toilet purposes
A61K 38/17 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from humans

Patent holdings for IPC class A61K 38/17

944	957	987	1179	1191	1414	1421	1334	1302	463
2013	2014	2015	2016	2017	2018	2019	2020	2021	2022

Owner	All patents	This class
The Regents of the University of California	18044	303
Immatics Biotechnologies GmbH	958	166
Inserm (institut National de La Sante et de La Recherche Medicale)	2910	159
The Board of Trustees of the Leland Stanford Junior University	5485	157
Centre National de La Recherche Scientifique	9430	128
Acceleron Pharma Inc.	365	127
The Trustees of the University of Pennsylvania	3911	126
Regeneron Pharmaceuticals, Inc.	2751	115
Dana-Farber Cancer Institute, Inc.	2343	110
The United States of America, as represented by the Secretary, Department of Health and Human Services	2397	105
The General Hospital Corporation	4417	96
Genentech, Inc.	3970	94
Novartis AG	13334	89
The Johns Hopkins University	5017	89
The Brigham and Women's Hospital, Inc.	2028	86
Board of Regents, The University of Texas System	5078	81
Children's Medical Center Corporation	1667	81
Institut National de La Sante et de La Recherche Medicale (inserm)	2191	80
President and Fellows of Harvard College	5426	75
Amgen Inc.	3448	71
Other owners		13840